Authors:
Olsen, E
Duvic, M
Frankel, A
Kim, Y
Martin, A
Vonderheid, E
Jegasothy, B
Wood, G
Gordon, M
Heald, P
Oseroff, A
Pinter-Brown, L
Bowen, G
Kuzel, T
Fivenson, D
Foss, F
Glode, M
Molina, A
Knobler, E
Stewart, S
Cooper, K
Stevens, S
Craig, F
Reuben, J
Bacha, P
Nichols, J
Citation: E. Olsen et al., Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma, J CL ONCOL, 19(2), 2001, pp. 376-388
Authors:
Cruz, JC
Alsina, M
Craig, F
Yoneda, T
Anderson, JL
Dallas, M
Roodman, GD
Citation: Jc. Cruz et al., Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma, EXP HEMATOL, 29(4), 2001, pp. 441-447
Authors:
Anderson, JE
Tefferi, A
Craig, F
Holmberg, L
Chauncey, T
Appelbaum, FR
Guardiola, P
Callander, N
Freytes, C
Gazitt, Y
Razvillas, B
Deeg, HJ
Citation: Je. Anderson et al., Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis, BLOOD, 98(3), 2001, pp. 586-593
Authors:
Choi, SJ
Cruz, JC
Craig, F
Chung, H
Devlin, RD
Roodman, GD
Alsina, M
Citation: Sj. Choi et al., Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma, BLOOD, 96(2), 2000, pp. 671-675
Authors:
Craig, F
Leiper, AD
Stanhope, R
Brain, C
Meller, ST
Nussey, SS
Citation: F. Craig et al., Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index, ARCH DIS CH, 81(6), 1999, pp. 500-504